USAID's $2.9B GHSC IDIQ contract for malaria programs shows strong performance but faces long-term sustainability questions

Contract Overview

Contract Amount: $2,925,878,094 ($2.9B)

Contractor: Chemonics International, Inc.

Awarding Agency: Agency for International Development

Start Date: 2015-04-20

End Date: 2026-11-28

Contract Duration: 4,240 days

Daily Burn Rate: $690.1K/day

Competition Type: FULL AND OPEN COMPETITION

Pricing Type: COST PLUS FIXED FEE

Sector: Other

Official Description: IGF::CL::IGF - GHSC IDIQ - MALARIA TASK ORDER

Place of Performance

Location: WASHINGTON, DISTRICT OF COLUMBIA County, DISTRICT OF COLUMBIA, 20006

State: District of Columbia Government Spending

Plain-Language Summary

Agency for International Development obligated $2.93 billion to CHEMONICS INTERNATIONAL, INC. for work described as: IGF::CL::IGF - GHSC IDIQ - MALARIA TASK ORDER Key points: 1. Contract demonstrates effective delivery of critical malaria-related services globally. 2. Competition was robust, suggesting fair pricing and value for taxpayer dollars. 3. Long contract duration and significant value indicate a high level of trust and performance. 4. Potential risks include contractor dependency and the long-term sustainability of malaria programs. 5. This contract is a cornerstone of USAID's global health security initiatives. 6. Performance metrics, while not detailed here, are crucial for assessing true value-for-money.

Value Assessment

Rating: good

The contract's total value of nearly $3 billion over its lifespan suggests a significant investment in global health. Benchmarking against similar large-scale, multi-year global health contracts managed by USAID or other development agencies would be necessary for a precise value-for-money assessment. However, the full and open competition indicates a structured procurement process likely aimed at achieving competitive pricing. The cost-plus-fixed-fee (CPFF) contract type, while common for complex services, requires careful oversight to manage costs effectively and ensure the fixed fee remains reasonable.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that multiple qualified vendors had the opportunity to bid. This approach typically fosters a competitive environment, driving down prices and encouraging innovation. The presence of multiple bidders suggests a healthy market for these types of global health services. The specific number of bidders is not provided, but the 'full and open' designation is a positive indicator for price discovery and taxpayer value.

Taxpayer Impact: A full and open competition generally benefits taxpayers by ensuring that the government receives the best possible value through a competitive bidding process, preventing inflated costs that might arise from sole-source or limited competition awards.

Public Impact

Beneficiaries include populations in malaria-endemic countries receiving essential health services and supplies. Services delivered encompass a wide range of malaria prevention, treatment, and control activities. Geographic impact is global, focusing on regions with high malaria burdens. Workforce implications include local employment in implementing countries and support for global health professionals.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Long-term reliance on a single contractor for critical global health programs could create dependency.
The CPFF contract type necessitates robust oversight to prevent cost overruns beyond the fixed fee.
Sustainability of malaria programs beyond the contract's end date is a potential concern.
Geopolitical shifts or changes in funding priorities could impact program continuity.

Positive Signals

The contract's significant value and long duration suggest a high level of contractor performance and reliability.
Full and open competition indicates a well-managed procurement process likely resulting in competitive pricing.
The focus on malaria aligns with critical global health priorities, indicating strategic alignment.
The contract supports a vital public health mission with demonstrable impact.

Sector Analysis

This contract falls within the broader professional services sector, specifically administrative management and general management consulting, applied to global health initiatives. The market for such services is substantial, involving numerous large and small firms specializing in international development, public health, and logistics. USAID's spending in this area is significant, reflecting the U.S. government's commitment to combating infectious diseases globally. Comparable spending benchmarks would involve analyzing other large IDIQs for global health programs across agencies like PEPFAR, CDC, and the Global Fund.

Small Business Impact

While the data indicates the prime contractor is not a small business and there's no explicit small business set-aside mentioned (ss: false, sb: false), large IDIQ contracts like this often have subcontracting plans. These plans can create opportunities for small businesses to participate in specific service delivery or supply chain components. The extent to which small businesses are utilized as subcontractors is a key factor in assessing the contract's impact on the small business ecosystem.

Oversight & Accountability

Oversight for this contract is primarily managed by the Agency for International Development (USAID). As a Cost Plus Fixed Fee contract, rigorous financial and performance monitoring is essential. Transparency is typically facilitated through contract award databases and reporting requirements. The Inspector General's office for USAID would have jurisdiction to investigate any potential fraud, waste, or abuse related to this contract.

Related Government Programs

PEPFAR (President's Emergency Plan for AIDS Relief)
Global Fund to Fight AIDS, Tuberculosis and Malaria
President's Malaria Initiative
USAID Global Health Supply Chain Program

Risk Flags

Potential for cost overruns due to CPFF structure
Long-term program sustainability beyond contract period
Contractor performance variability on complex global projects
Geopolitical risks impacting service delivery in target countries

Frequently Asked Questions

What is this federal contract paying for?

Agency for International Development awarded $2.93 billion to CHEMONICS INTERNATIONAL, INC.. IGF::CL::IGF - GHSC IDIQ - MALARIA TASK ORDER

Who is the contractor on this award?

The obligated recipient is CHEMONICS INTERNATIONAL, INC..

Which agency awarded this contract?

Awarding agency: Agency for International Development (Agency for International Development).

What is the total obligated amount?

The obligated amount is $2.93 billion.

What is the period of performance?

Start: 2015-04-20. End: 2026-11-28.

What is the track record of Chemonics International, Inc. on similar large-scale USAID contracts?

Chemonics International, Inc. is a well-established government contractor with extensive experience in international development and global health. They have a history of managing large, complex contracts for USAID and other U.S. government agencies, often involving supply chain management, technical assistance, and program implementation in challenging environments. While specific performance details for this GHSC IDIQ are not provided in the summary data, Chemonics generally has a reputation for capability in executing such programs. However, like any large contractor, they may have faced scrutiny or performance issues on specific contracts, which would typically be documented in performance evaluations and IG reports. A deeper dive into their past performance ratings and any significant contract disputes or corrective actions would be necessary for a comprehensive assessment.

How does the total contract value of $2.9 billion compare to other major global health initiatives funded by USAID?

The $2.9 billion total obligated amount for this GHSC IDIQ is substantial and places it among USAID's largest contracts, particularly within the global health sector. For context, major initiatives like the President's Malaria Initiative (PMI) have annual budgets in the hundreds of millions of dollars, and the overall PEPFAR program represents billions in funding over its lifespan. This IDIQ's value reflects its broad scope, covering multiple aspects of health supply chain management and program support across various countries. It is comparable to other large, multi-year Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles designed to provide flexible and responsive support for complex, long-term development challenges. The scale indicates a significant strategic investment by USAID in strengthening health systems.

What are the primary risks associated with a Cost Plus Fixed Fee (CPFF) contract of this magnitude?

The primary risks associated with a Cost Plus Fixed Fee (CPFF) contract of this magnitude, like the GHSC IDIQ, revolve around cost control and contractor incentive. While the fixed fee provides the contractor with a defined profit margin, the 'cost plus' component means the government reimburses allowable costs incurred by the contractor. This structure can incentivize contractors to incur higher costs if oversight is not rigorous, as their fee is fixed regardless of the total cost. Key risks include potential for cost overruns if the scope is not well-defined or if unforeseen challenges arise, and the need for robust auditing and monitoring by USAID to ensure costs are reasonable, allocable, and allowable. Contractor performance and efficiency are critical to ensure the overall value proposition of the contract is met.

What is the expected impact of this contract on global malaria control efforts?

This contract is expected to have a significant positive impact on global malaria control efforts by ensuring the reliable supply of essential malaria commodities, such as insecticide-treated nets, diagnostic tests, and antimalarial drugs, to countries in need. It also supports the implementation of malaria prevention and treatment programs through technical assistance and capacity building. By strengthening the health supply chain, the contract helps reduce stockouts and improve the efficiency of service delivery. Ultimately, this contributes to USAID's broader goals, including those of the President's Malaria Initiative (PMI), to reduce malaria morbidity and mortality, particularly among vulnerable populations like pregnant women and children under five.

How has USAID's spending on malaria programs evolved over the life of this contract?

The GHSC IDIQ was awarded in April 2015, and its task orders would have been issued and executed over subsequent years, extending through November 2026. USAID's spending on malaria programs, often channeled through initiatives like the President's Malaria Initiative (PMI), has generally seen substantial and sustained funding over this period, reflecting a consistent U.S. government commitment. While this specific IDIQ represents a significant portion of the funding for supply chain and related services, overall malaria program spending by USAID has remained robust, often fluctuating based on congressional appropriations and global health priorities. Analyzing annual reports from PMI and USAID's budget documents would provide a detailed year-over-year breakdown of malaria-related expenditures.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Administrative Management and General Management Consulting Services

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 1275 NEW JERSEY AVE SE STE 200, WASHINGTON, DC, 20003

Business Categories: Category Business, Not Designated a Small Business, Special Designations, Subchapter S Corporation, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $3,295,901,478

Exercised Options: $3,295,901,478

Current Obligation: $2,925,878,094

Actual Outlays: $1,652,417,465

Subaward Activity

Number of Subawards: 544

Total Subaward Amount: $1,828,312,866

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: YES

Parent Contract

Parent Award PIID: AIDOAAI1500004

IDV Type: IDC

Timeline